Skip to content
Trial Eligibility
Menu

Immediate Postpartum Glucose Tolerance Testing

NCT04199676

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

The objective of this study is to compare the accuracy of a 2hr glucose tolerance test administered during the postpartum hospitalization with the standard of care glucose tolerance testing (administered at 6 weeks postpartum). The primary hypothesis is that the glucose tolerance test administered in the postpartum period will be accurate and will improve compliance with postpartum testing for gestational diabetics.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Gestational Diabetes

Eligibility basics and study details

Study type
Observational
Phase
Not applicable
Ages
18 years and older
Sex
Female
Healthy volunteers
Accepted
Sponsor
MemorialCare Health System
Last updated on ClinicalTrials.gov
September 3, 2025

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

California · 1

  • Long Beach Memorial Medical Center/Miller Children's and Women's Hospital · Long Beach, CA

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.